Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Clinical and Translational Endocrinology: Case Reports is Scopus-indexed (Q4, CiteScore 1), DOAJ. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 2214-6245Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 201 / 250 | 19th | Q4 |
| Endocrinology | 120 / 132 | 9th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q4, CiteScore 1.
Journal of Clinical and Translational Endocrinology: Case Reports is Q4 in Endocrinology, Diabetes and Metabolism (rank 201 of 250) and Q4 in Endocrinology (rank 120 of 132), by CiteScore 2025.
Journal of Clinical and Translational Endocrinology: Case Reports is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1, quartile Q4, 19th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.168, quartile Q4, with an H-index of 7.
The publisher lists an article processing charge of about US$1,260 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Clinical and Translational Endocrinology: Case Reports is published by Elsevier Inc. Its ISSN is 2214-6245.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Journal of Clinical and Translational Endocrinology: Case Reports has an h-index of 8 and a 2-year mean of 0.41 citations per paper (OpenAlex). Its Scopus CiteScore is 1, quartile Q4. On 2-year citations it ranks #206 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Journal of Clinical and Translational Endocrinology: Case Reports published 26 papers in 2025; its busiest recent year was 2022 with 31. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2022–2026), authors are most often from United States (34.9%), India (7.4%) and Iran (6.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (4.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.